09/30/2020
Top Buys
- Name% Change
- NBIX Neurocrine Bioscien... 2.47%
- XLRN Acceleron Pharma Inc 2.0%
- BHVN Biohaven Pharmaceut... 1.85%
- ACAD Acadia Pharmaceutic... 1.59%
- IOVA Iovance Biotherapeu... 1.54%
09/30/2020
Top Sells
- Name% Change
- IMMU Immunomedics Inc. 3.73%
- CCXI ChemoCentryx, Inc. 3.06%
- ZGNX Zogenix Inc 2.05%
- ENTA Enanta Pharmaceutic... 0.76%
- SAGE Sage Therapeutics Inc 0.52%
09/30/2020
13F Holdings Summary
- Stock% Port
- HZNP Horizon Therapeutics PLC 9.76%
- NBIX Neurocrine Biosciences Inc. 6.89%
- GILD Gilead Sciences Inc. 6.55%
- ACAD Acadia Pharmaceuticals Inc 6.47%
- BMRN BioMarin Pharmaceutical Inc 6.07%
09/30/2020
13F Activity
- Market Value $309.768 Million
- Prior Market Value $300.837 Million
- New Purchases5 stocks
- Additional Purchases12 stocks
- Sold out of5 stocks
- Reduced holdings in7 stocks
- Top 10 Holdings % 58.20 %
- Turnover % [1]:18.87%
- Turnover Alt % [2]: 14.47 %
- Time Held Top20:5.85 quarters
- Time Held Top10:4.10 quarters
- Time Held All:8.11 quarters
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
09/30/2020
13F Sector Allocation Over Time
Fund Metrics
You are limited to the prior 8 quarters of 13F filings. Subscribe to WhaleWisdom to view all filing data for INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Risk/Reward Analysis
Portfolio Market Cap Analysis
Portfolio Performance
Top 20 equal-weighted holdings. Performance numbers calculated through 2020-08-14
| Performance for Q2 2020: | 3.76% |
| Performance Last 4 Quarters: | 30.66% |
Performance Metrics
Stats are not available for the latest quarter
